AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04823429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High intensity-interval training (HIIT)
Description: Subjects performed HIIT (3-min intervals at 40% and 80%VO2peak) on a bicycle ergometer for 30 min/day, 5 days/week for 6 weeks.~Without any exercise training
Study NCT04823429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate intensity-continuous (MICT)
Description: Subjects performed MICT (sustained 60%VO 2max) on a bicycle ergometer for 30 min/day, 5 days/week for 6 weeks.
Study NCT06205303 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Decision Aid (Video)
Description: Patient decision aid on thyroxine replacement is a video designed to assist the hypothyroid adults with under-replacement. It provides clear and balanced information about hypothyroidism, the role of thyroxine, treatment benefits, potential risks, and factors interfering thyroxine absorption and bioavailability. The PDA aims to empower patients to engage in shared decision-making with their healthcare provider, ensuring they understand the options and can make choices aligned with their preferences and values.
Study NCT06011941 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified laparoscopic transcystic biliary drainage
Description: First, a needle was passed through a separate skin puncture wound 3 cm below the costal margin on the midaxillary line/posterior axillary line. Second, a lateral incision into the cystic duct was performed medially to allow insertion and embedding of the catheter. Third, a 7-Fr catheter was introduced through the abdominal wall via the cystic duct into the CBD. Fourth, if the position of the catheter inside the CBD was correct (the end of the tube reached the distal CBD but did not pass the papilla), the lateral incision of the cystic duct was closed by a V-Loc closure device using a single-layered, continuous suture in a circling manner to simultaneously cover and anchor the C-tube. After the procedure, an artificial fistula of 3 to 5 mm in length was formed.
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: THC-dominant cannabis
Description: Smoked cannabis with 9.53% THC and 0.09% CBD
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THC-dominant cannabis
Description: Smoked cannabis with 9.53% THC and 0.09% CBD
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: CBD-dominant cannabis
Description: Smoked cannabis with 0.35% THC and 11.27% CBD
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD-dominant cannabis
Description: Smoked cannabis with 0.35% THC and 11.27% CBD
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cannabis placebo
Description: Smoked placebo cannabis plant material
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis placebo
Description: Smoked placebo cannabis plant material
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: Drink containing 0.3 g/kg of alcohol
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alcohol
Description: Drink containing 0.3 g/kg of alcohol
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcohol placebo
Description: Placebo beverage contains only juice and a negligible trace of alcohol for masking
Study NCT06136975 — intervention group
Intervention type: DEVICE
Intervention: Low-level laser therapy
Description: The treatment was once a week for eight weeks. The patient was in a supine position. The gain medium of the laser was Gallium-Aluminum-Arsenide. The laser was introduced into vagina via a silicon vaginal probe inserted by a doctor for 30 minutes (wavelength 660nm, power density 18.17mW/cm2, energy density 0.018J/cm2s, total energy density 32.4J/cm2).
Study NCT05389930 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alcohol placebo
Description: Placebo beverage contains only juice and a negligible trace of alcohol for masking
Study NCT05225870 — intervention group
Intervention type: GENETIC
Group type: OTHER
Intervention: immunohistochemical staining
Description: sections from colorectal carcinoma will be immunohistochemically stained by anti-Cortactin antobody.
Study NCT04830072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief AWARD advice and active referral to somking cessation services
Description: The AWARD advice includes: (1) Ask about smoking history; (2) Warn about the high risk of smoking; (3) Advise to quit or reduce smoking as soon as possible; (4) Refer smokers to smoking cessation services (with a referral card); (5) Do it again: to repeat the intervention.
Study NCT04830072 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief AWARD advice and active referral to somking cessation services
Description: The AWARD advice includes: (1) Ask about smoking history; (2) Warn about the high risk of smoking; (3) Advise to quit or reduce smoking as soon as possible; (4) Refer smokers to smoking cessation services (with a referral card); (5) Do it again: to repeat the intervention.
Study NCT04830072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Chat-based support through Instant Messaging apps
Description: Participants in the intervention group will receive 3 months of chat-based support through Instant Messaging apps (e.g., WhatsApp, WeChat). The support mainly includes (1) regular messages on health warnings, benefits and methods of quitting, coping craving approach, and promotion to use the SC services; (2) real-time, personalized, and interactive behavioral and psychosocial support through Instant Messaging apps.
Study NCT04830072 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Chat-based support through Instant Messaging apps
Description: Participants in the intervention group will receive 3 months of chat-based support through Instant Messaging apps (e.g., WhatsApp, WeChat). The support mainly includes (1) regular messages on health warnings, benefits and methods of quitting, coping craving approach, and promotion to use the SC services; (2) real-time, personalized, and interactive behavioral and psychosocial support through Instant Messaging apps.
Study NCT04830072 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Leaflet
Description: Leaflet on harms of smoking
Study NCT04830072 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Leaflet
Description: Leaflet on harms of smoking
Study NCT04830072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AR images
Description: AR images of the harms of smoking and the benefit of abstinence.
Study NCT04763057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NeoPUTTY MTA
Description: NeoPUTTY, a premixed bioactive bioceramic MTA that triggers hydroxyapatite and supports healing
Study NCT04763057 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: calcium hydroxide
Description: Calcium hydroxide the gold standard for IPT
Study NCT06472596 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CBC, CRP ,ESR, ABG , interleukin 6, tumor necrotic factor alpha
Description: compare results of investigations in asthmatics and non asthmatics
Study NCT05973448 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Novel Lighting Condition
Description: Horizontal and vertical lights over a doorway visible from the bed
Study NCT05973448 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Lighting Condition
Description: Standard night light plugged into wall socket
Study NCT04820842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-994
Description: TAK-994 tablets.
Study NCT04820842 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo-matching tablets.
Study NCT05464056 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Be Unstoppable in Life Together (BUILT)
Description: Participants will complete weekly sleep, food, and exercise home challenges focused on creating sustainable healthy eating, sleep, and exercise routines. Parents will participate in weekly support calls by UIC and Chicago Park District staff to provide support and accountability. Children will have the opportunity to win small prizes based on completing weekly challenges. The intervention will be co-facilitated by UIC students and Chicago Park District staff and will largely take place on-line. For additional details visit: https://built.ahs.uic.edu.
Study NCT05816070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IVIEW-1201
Description: Four times per day for day 1-2 and three times per day for day 3-7
Study NCT05816070 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ofloxacin Eye Drops
Description: Four times per day for day 1-2 and three times per day for day 3-7
Study NCT04766268 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prostate artery embolization
Description: Prostate artery embolization (PAE) is a safe and effective minimally invasive interventional radiology procedure in which intraprostatic vessels are embolized to shrink the size of the prostate gland. LUTS is mainly categorized into irritative, obstructive, and mixed types. This has a variable impact on patients' quality of life by interfering with sleep, activities of daily living, anxiety, mobility, leisure, and effect on sexual activities. This trial aims to determine safety and effectiveness of prostate artery embolization and determine factors associated with improved procedure outcome.
Study NCT04515459 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Surgical prehabilitation program.
Description: This programme will include the practice of general physical activity and the implementation of nutritional and psychological support.~Each patient will have 8 Oncorehabilitation Transdisciplinary Evaluations (OTE):~* 2 OTE will be performed before the surgery,~* 6 OTE will be performed after the surgery.~During the program (at each OTE), patients will also be asked to complete the QLQ-C30 questionnaire.
Study NCT05098093 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: SBE
Description: Hard-shell capsule
Study NCT05098093 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: DBE
Description: Hard-shell capsule
Study NCT05098093 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: BP
Description: Hard-shell capsule
Study NCT04844580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled Aviptadil
Description: Aviptadil is the synthetic analogue of the Vasoactive Intestinal Peptide (VIP), a biologically active 28 amino acid natural peptide that is endogenously synthesized in humans. It is one of the signaling molecules of the neuroendocrine immune network and has vasodilator, anti-proliferative, anti-inflammatory and immunomodulatory properties.
Study NCT04844580 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Aviptadil Placebo will be used for this arm.
Study NCT06048770 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RBI-4000
Description: RBI-4000 intramuscular injection.
Study NCT06048770 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: RabAvert
Description: RabAvert intramuscular injection.
Study NCT06578286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: ARX788，1.5 mg/kg IV infusion on Day 1 of each 21-day treatment cycle
Study NCT05855330 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Arginine Hydrochloride
Description: Arginine will be infused based on the manufacturer's instructions (R-Gene 10, Pfizer), over 30 minutes. However, rates may be slowed to over 60 minutes for patients experiencing symptoms of flushing, nausea, vomiting, or headache at the research team's discretion. Pediatric doses will be drawn up by the pharmacy.
Study NCT05525273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral dabrafenib and trametinib
Description: Neoadjuvant or postoperative treatment of patients with verified BRAF mutated papillary craniopharyngioma
Study NCT05563194 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heating prototype (Prototype 1)
Description: A wearable that heats and vibrates to help distract from pain. It can be wrapped around any joint with temperature and vibration settings allowing CYP to set the device to their needs.
Study NCT05563194 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Physio tool (Prototype 2)
Description: A motivational physiotherapy tool that incrementally lights up as the CYP do their prescribed stretches, emphasising a sense of progression and making it a more engaging activity.
Study NCT05563194 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Communication tool (Prototype 3)
Description: A wearable to help communication in the classroom between the teacher and pupil. The child can alert the teacher if they need help, through vibration, without attracting the attention of their classmates, reducing embarrassment.
Study NCT05238493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VEL-101
Description: Intervention administered via subcutaneous injection or 1-hour intravenous infusion on Day 1
Study NCT05238493 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intervention administered via subcutaneous injection or 1-hour intravenous infusion on Day 1
Study NCT06074120 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Description: Low-level laser therapy would be introduced via a vaginal probe (gain medium: Gallium-Aluminum-Arsenide, wavelength 660nm) for 30 minutes per treatment, once a week, for 8 courses.
Study NCT04480411 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Doctorgram Patient Kit
Description: Participants will use the Doctorgram Patient Kit for remote monitoring and remote use stethoscope.
Study NCT04725344 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACTIV'DOS group
Description: ACTIV'DOS group use ACTIV'DOS application (with smartphone) to do the self rehabilitation each day (15 minutes per day) during 6 weeks. There are 7 exercices.
Study NCT04725344 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual practise
Description: Control group uses a standard sheet of paper to do the self-rehabilitation (15 minutes per day) during 6 weeks. There are 7 exercises.
Study NCT06015633 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Observational only
Study NCT05322941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AEF0117
Description: AEF0117 (1.0, 0.3, and 0.1 mg) capsules
Study NCT05322941 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: Corn oil capsule manufactured to mimic AEF0117 capsule
Study NCT05259462 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Participants will utilize low-cost, consumer available head-mounted displays to meet with peers and coaches online. The program will last 4 weeks and include 2 x 1-hour sessions per week of supervised peer-to-peer gaming. The coaches will utilize behavioral change and mindfulness techniques to promote autonomy, competence, and relatedness through a respectful, cohesive, and positive atmosphere. These strategies will be framed by the Self-Determination Theory and learned from the National Center on Health, Physical Activity, and Disability (NCHPAD) mindfulness coaching workshops. Some of the mindfulness-based strategies will include guided breathing focused exercises, body scanning, meditation, and acceptance of social anxiety and shyness
Study NCT06234410 — intervention group
Intervention type: RADIATION
Intervention: Computed tomography coronary angiography (CTCA)
Description: Single CTCA scan prior to kidney transplantation
Study NCT04076410 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Z1 lens
Description: CE marked device
Study NCT04076410 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Lens 1
Description: CE marked device
Study NCT04076410 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Lens 2
Description: CE marked device
Study NCT04076410 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Lens 3
Description: CE marked device
Study NCT04076410 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Lens 4
Description: CE marked device
Study NCT05548101 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ICSI
Description: Using the injecting pipet, one sperm will be isolated. Using the tip of the injecting pipet, the sperm tail will be broken by trapping it between the pipet and bottom of the dish. The sperm will be picked up in the pipet. The oocyte will be positioned so the polar body is at the 12 o'clock or 6 o'clock position. The sperm injecting pipet will be positioned at the 3 o'clock position of the oocyte. The injecting pipet will be advanced into the oocyte cytoplasm and the cytoplasm will be gently aspirated until the oocyte membrane breaks. The sperm will then be injected into the cytoplasm of the oocyte. The pipet will then be withdrawn from the oocyte.
Study NCT06492824 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enjoyable Activities Condition
Description: Participants complete an introduction video about the intervention. They will then take a pre-intervention survey, after which they will choose five enjoyable activities from a large list. Daily text message reminders will be sent to BA participants in the morning to remind them to do their enjoyable activities for the day, as well as a link to a checklist where they will report how frequently they have completed any of their five activities from the previous day (example text message in documentation). At the end of the month, they will complete a follow-up survey consisting of the same measures from the pre-intervention survey.
Study NCT06492824 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Activities Condition
Description: They will take a pre-intervention survey and choose five enjoyable activities from the same list; however, active control participants will not explicitly be asked to complete these activities for the intervention. Participants in the active control condition will be promoted to complete tasks such as drinking more water, going to bed early, brushing their teeth, showering or bathing for that day, and eating well balanced meals. Daily text reminders will be sent about these healthy living activities in the morning. In that same message, they will receive a link to a checklist where they will report about their completed healthy living activities for the previous day (example text message in documentation). At the end of the month, they will also complete a follow-up survey consisting of the same measures from the pre-intervention survey.
Study NCT06111222 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: HECATE
Description: The device is CE-approved. The device is a posterior chamber multifocal intraocular lens (IOL) indicated for aphakia after surgical extraction of the cataractous natural lens. The device is also indicated for non-cataractous, presbyopic patients (PRELEX) who seek greater independence from glasses for intermediate and/or near distances. It is an aspheric (aberration-neutral) IOL made of hydrophobic acrylic material, coated with heparin with modified C-loop haptics.
Study NCT06085430 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kubota Glass
Description: Kubota Glass employs white light producing micro-LEDs covered by masks which create a patterned target. The patterned images are defocused by micro-lenslets and projected to the retinal periphery by a central mirror. Parameters of interest to evaluate in this investigation include but are not limited to dioptric amount of defocus, brightness (cd/m2), spectrum of illumination, and shape of the target mask. In each scenario, right eyes will be exposed to the stimulus, whereas left eyes serve as controls. The order of exposures to the various stimuli will be randomized to participant and investigator.
Study NCT05828979 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UroMems artificial urinary sphincter
Description: Implantation of the device
Study NCT06701435 — intervention group
Intervention type: DEVICE
Intervention: Cold Compression
Description: Cold compression was applied to the athletes with the Game Ready (Game Ready; Global, UK) device. The Game Ready (GR) device applies cooling to the tissue by continuous circulation of ice water with intermittent pneumatic compression. The GR consists of a sleeve that surrounds the affected tissue, a tank containing the ice water and a hose connecting the two. There are chambers inside the sleeve and the air pumped through these chambers and the broken ice pieces and water surround the tissue. The pressure settings are no compression (0 mmHg), low compression (5 to 15 mmHg), medium compression (5 to 50 mmHg) and high compression (5 to 75 mmHg). The ice water passes through the sleeve in 3-minute inflation and deflation cycles. The temperature of the water inside the device can be adjusted by adding ice and water. The temperature to be applied to the tissue is set with the screen on the device.
Study NCT06721026 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Continuous intravenous stable isotope amino acid tracer infusion
Description: During the single 12 h trial day, a primed continuous stable isotope infusion will run in order to assess muscle protein synthesis in the basal (4 h) and post-prandial (8 h) state.
Study NCT06721026 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Amino acid infusion
Description: In order to assess muscle protein synthesis rates during continuous elevated plasma amino acid availability, the amino acid infusion solution Vamin®14 EF will be used. Vamin® 14EF contains 85g amino acids per liter and will be administered in the post-prandial period for 8 hours to ensure a constant rate of amino acid infusion over the full assessment period of the primary outcome measure.